Sulmaz Ghahramani

Dr. Sulmaz Ghahramani


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Korean Journal of Medical Education
Verified
Journal Article
Open access
PDF file
SGSulmaz Ghahramani
Sulmaz Ghahramani
AJAliReza Torabi Jahromi
AliReza Torabi Jahromi
DKDanial Khoshsoroor
Danial Khoshsoroor
RSReza Seifooripour
Reza Seifooripour
MSMinoo Sepehrpoor
Minoo Sepehrpoor
Emotional intelligence is a factor affecting the health of individuals, and happiness is another factor affecting it. Medical students' health can greatly affect a community's health due to the important role of medical students in maintaining and improving it. Accordingly, we aimed to study the relationship between emotional intelligence and happiness among the students of the Shiraz Medical School. This study is an analytical, cross-sectional study. The target population of this study was the medical students who began studying in the medical school and the international branch of Shiraz University of Medical Sciences from September 2014 to September 2017. The sample size was 300 students who were selected by a systematic sampling method. The instruments for collecting information in this study were Oxford Happiness Inventory and Siberia Schering's Emotional Intelligence Questionnaire. The significance level of the tests was set at 0.05. The mean age of 292 responded participants were 20.73 with standard deviation of ±1.81 emotional intelligence (p<0.001), level of stress (p<0.001), and grade (p=0.03) and type of personality (p<0.001) can explain the changes in the happiness level and they were significant effective factors in the regression modeling. Emotional intelligence was a predictive factor for happiness in medical students. Students with higher emotional intelligence felt healthier. And happiness in extroverted students was higher than introverted ones. It is suggested that the results of this study should be confirmed with prospective studies.

1 June 2017 in Journal Of Hypertension
Verified
Journal Article
Closed access
PDF file
MAMaryam Akbari
Maryam Akbari
MMMahmood Moosazadeh
Mahmood Moosazadeh
SGSulmaz Ghahramani
Sulmaz Ghahramani
RTReza Tabrizi
Reza Tabrizi
FKFariba Kolahdooz
Fariba Kolahdooz
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
High blood pressure in children is a public health problem and the most important risk factor for cardiovascular disease at an older age. Several preliminary studies have been published regarding the prevalence of high blood pressure in which there was significant disparity. This study aimed to estimate the prevalence of hypertension in Iranian children using the meta-analysis approach. A systematic search of national and international databases was conducted through September 30, 2015, for population studies providing estimates on the prevalence of hypertension in Iranian children and adolescents. From the extracted prevalence rates, the heterogenic index of the studies was determined using Cochran's (Q) and Chi-squared (I2) tests, and on the basis of the heterogenetic results, a fixed or random effects model was employed to estimate the pooled prevalence rate of hypertension. Meta-regression was performed to determine those factors suspected of generating heterogeneity. Of 2360 articles initially identified, 17 were considered eligible. The meta-analyses included 79 231 children and adolescents aged between 3 and 18 years. The pooled prevalence of hypertension among children and adolescents was estimated to be 8.9% [95% confidence interval (95% CI): 7.5–10.3] in overall, 10.3% (95% CI: 7.5–12.6) in males and 9.1% (95% CI: 7.4–10.7) in females. The prevalence rates of high DBP and SBP were estimated at 6.6% (95% CI: 3.9–9.2) and 6.9% (95% CI: 5.6–8.2), respectively. There is a high prevalence of hypertension among Iranian children and adolescents. Although it is slightly higher among boys than girls, the difference was not statistically significant.

19 January 2023 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
MPMajid Pakdin
Majid Pakdin
LZLeila Zarei
Leila Zarei
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
SGSulmaz Ghahramani
Sulmaz Ghahramani
Background: Inflammatory bowel disease (IBD) is a chronic inflammatory condition involving individuals across all age groups. Recent data suggests the increase in the prevalence of IBD and the surge in applying the biologic drugs in which both change the cost of IBD in recent years. Comprehensive assessment of direct and indirect cost profiles associated with IBD in our area is scarce. This study aimed to determine the economic burden of IBD in Iran from a societal perspective, using cost diaries. Methods: Patients available on clinic registry and hospital information system (HIS), who were diagnosed with IBD, were invited to take part in this study. Demographic and clinical data, the healthcare resource utilization or cost items, absenteeism for the patients and their caregivers were obtained. The cost of the used resources were derived from national tariffs. The data regarding premature mortality in IBD patients was extracted from HIS. Productivity loss was estimated based on the human capital method. Then, cost date were calculated as mean annual costs per patient. Results: The cost diaries were obtained from 240 subjects (Ulcerative colitis: n = 168, Crohn’s disease, n = 72). The mean annual costs per patient were 1077 US$ (95% CI 900–1253), and 1608 (95% CI 1256, 1960) for the patients with ulcerative colitis and Crohn’s disease, respectively. Of the total costs, 58% and 63% were in terms of the indirect costs for the patients with ulcerative colitis and Crohn’s disease, respectively. The cost of illness for country was found to be 22,331,079 US$ and 15,183,678 US$ for patients with ulcerative colitis and Crohn’s disease, respectively. Highest nationwide economic burden of IBD was found for patients older than 40 years were estimated to be 8,198,519 US$ and 7,120,891 US$, for ulcerative colitis and Crohn’s disease, respectively. Conclusion: The medication was found to be the greatest contributor of direct medical costs. Productivity loss in terms of long-term disability and premature mortality were major components of IBD’s economic burden in Iran.

31 August 2022 in Archives of Public Health
Verified
Journal Article
Open access
PDF file
FEFatemeh Emadi
Fatemeh Emadi
AGArash Ghanbarzadegan
Arash Ghanbarzadegan
SGSulmaz Ghahramani
Sulmaz Ghahramani
PBPeivand Bastani
Peivand Bastani
MBMelissa T Baysari
Melissa T Baysari
Background: Medication adherence among older adults (aged 60 and above), particularly those with chronic conditions who take several medications, is critical, and tele-pharmacy services are a way to improve medication adherence. This study sought to determine the factors influencing medication adherence (MA) in older adults using tele-pharmacy services.Method: The Joana Briggs Institute scoping review methodology was implemented. Searches were conducted in databases PubMed, Scopus, ProQuest, Web of Science, and Embase from 2000 to the present day, to identify both qualitative and quantitative studies focusing on the use of tele-pharmacy by older people. Factors impacting MA were extracted and analyzed into themes using a qualitative approach. A concept map was also designed summarising these factors.Results: Of 7495 articles obtained in the initial search, 52 articles met the inclusion criteria. The analysis resulted in 5 themes and 21 sub-themes representing factors that impacted MA with tele-pharmacy. These themes are divided broadly into technology and user related factors. Technology factors included design of the tele-pharmacy intervention, commercial aspects, and adherence measurement method. User factors included user-health constraints, behaviors and perceptions.Conclusion: Industry, policymakers, and stakeholders should consider using tele-pharmacy services for improving medication adherence among older adults; however, ensuring interventions facilitate communication between patients and health care teams, and are accompanied by user training and support, is essential for technology uptake and effectiveness.

8 December 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
SMSeyed Ali Malek-Hosseini
Seyed Ali Malek-Hosseini
SNSaman Nikeghbalian
Saman Nikeghbalian
MDMohsen Dehghani
Mohsen Dehghani
MPMohammad Pourhashemi
Mohammad Pourhashemi
BGBita Geramizadeh
Bita Geramizadeh
Liver transplantation is a potential cure for liver damage from Wilson’s disease but the course of neuropsychiatric manifestations after transplantation remains undetermined. In this study, data on all patients who’d received a liver transplant for Wilson’s disease at the Shiraz Organ Transplantation Center between December 2000 and March 2014 were reviewed and compared to data on a control group who’d received a liver transplant over the same period but due to other causes. Out of 2198 patients who’d received a liver transplant in the period; 107 patients were diagnosed with Wilson’s disease (21 with fulminant hepatic failure); age of patient ranged from 5 to 59 years; 56.07% of patients in this series had some type of neuropsychiatric manifestation before transplantation, of which 66.67% showed improvement after the procedure. 18 patients had aggravation of neuropsychiatric symptoms after transplantation. These neuropsychiatric symptoms were mostly for anxiety, tremor and depression but there were four cases of new onset dysarthria, rigidity and ataxia in various combinations. Survival rates of 1-month, 1-year, and 5-years for patients with Wilson’s disease were 88%, 86%, 82%, respectively, evaluations were not statistically different from that of the control group. Liver transplantation showed good long-term results in patients with Wilson’s disease, even in those presenting fulminant hepatic failure. Neuropsychiatric manifestations normally show improvement after transplantation but in some cases new onset of manifestations occurred after successful liver transplantation.

20 August 2018 in Applied Health Economics and Health Policy
Verified
Journal Article
Closed access
PDF file
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
SGSulmaz Ghahramani
Sulmaz Ghahramani
NMNajmeh Moradi
Najmeh Moradi
HSHadi Raeisi Shahraki
Hadi Raeisi Shahraki
FLFarhad Lotfi
Farhad Lotfi
BHBehnam Honarvar
Behnam Honarvar